{"id":8398,"date":"2024-04-24T13:18:38","date_gmt":"2024-04-24T07:48:38","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&#038;p=8398"},"modified":"2024-10-04T17:07:49","modified_gmt":"2024-10-04T11:37:49","slug":"krystexxa-pegloticase-price-india","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/krystexxa-pegloticase-price-india\/","title":{"rendered":"KRYSTEXXA (pegloticase) Injection"},"content":{"rendered":"<h4>KRYSTEXXA (pegloticase) Injection is used to reduce the signs and symptoms of gout that are not controlled by other treatments used to lower blood uric acid levels in adults with gout. Generic Name: pegloticase Injection. Brand Name: KRYSTEXXA Injection.<\/h4>\n<h4 class=\"lh-sm small fst-italic\">What pegloticase is and used for?<\/h4>\n<p>Pegloticase (trade name Krystexxa) is a medication for the treatment of severe, treatment-refractory, chronic gout. It is a third line treatment in those in whom other treatments are not effective or are not tolerated. The drug is administered by infusion intravenously. Since October 2023, Amgen Inc. has been the marketer of pegloticase in the U.S.<\/p>\n<p>It was developed by Savient Pharmaceuticals. It was approved in the United States in 2010, after two clinical trials found it lowered uric acid levels and reduced deposits of uric acid crystals in joints and soft tissue. The European Medicines Agency (EMA) granted marketing authorization in 2013 for treatment of disabling tophaceous gout. In 2016 this authorization was ended at the request of Horizon Therapeutics PLC in Europe.<\/p>\n<h4>How can 1 go about obtaining KRYSTEXXA?<\/h4>\n<p>If<strong> KRYSTEXXA (pegloticase) Injection<\/strong>\u00a0are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n<p><em><strong>Note:<\/strong><\/em><br \/>\n<em>We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/em><\/p>\n<p><strong>NEWS \/ UPDATES<\/strong><\/p>\n<ul>\n<li class=\"lh-sm small fst-italic\"><a href=\"https:\/\/www.prnewswire.com\/news-releases\/amgen-presents-new-data-that-show-blood-pressure-decreases-for-adults-treated-with-krystexxa-pegloticase-301974970.html\" target=\"_blank\" rel=\"noopener\">Amgen presents new data that show blood pressure decreases for adults treated with krystexxa\u00ae (pegloticase)<\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<h2 class=\"display-6 mb-2 text-white lh-1\">KRYSTEXXA (pegloticase) Injection, for intravenous infusion Initial U.S. Approval: 2010<\/h2>\n<p>KRYSTEXXA (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy<\/p>\n<table style=\"width: 95%; height: 115px;\" border=\"1\" width=\"95%\">\n<tbody>\n<tr style=\"height: 23px;\">\n<td style=\"width: 21.8792%; height: 23px;\"><strong>Brand Name:<\/strong><\/td>\n<td style=\"width: 77.047%; height: 23px;\">KRYSTEXXA<\/td>\n<\/tr>\n<tr style=\"height: 23px;\">\n<td style=\"width: 21.8792%; height: 23px;\"><strong>Generic Name:<\/strong><\/td>\n<td style=\"width: 77.047%; height: 23px;\">pegloticase<\/td>\n<\/tr>\n<tr style=\"height: 23px;\">\n<td style=\"width: 21.8792%; height: 23px;\"><strong>Strength:<\/strong><\/td>\n<td style=\"width: 77.047%; height: 23px;\">1 mL sterile concentrate for dilution containing 8 mg of pegloticase protein, expressed in uricase protein amounts.<\/td>\n<\/tr>\n<tr style=\"height: 23px;\">\n<td style=\"width: 21.8792%; height: 23px;\"><strong>Manufacturer:<\/strong><\/td>\n<td style=\"width: 77.047%; height: 23px;\">Savient Pharmaceuticals, Inc.<\/td>\n<\/tr>\n<tr style=\"height: 23px;\">\n<td style=\"width: 21.8792%; height: 23px;\"><strong>Approved By:<\/strong><\/td>\n<td style=\"width: 77.047%; height: 23px;\">EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source Details: <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761240s000lbl.pdf\">Patient Information<\/a><\/p>\n<p><em><strong data-sider-select-id=\"0264f273-b082-496a-b3a6-36bbf779f0ec\">IPN, New Delhi can facilitate patient to import of &#8220;KRYSTEXXA (pegloticase) Injection&#8221;<\/strong> in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please\u00a0<a href=\"mailto:urgent@indianpharmanetwork.co.in\" target=\"_blank\" rel=\"noopener\">email IPN healthcare Support Team <\/a>for <strong>KRYSTEXXA (pegloticase) Injection<\/strong>\u00a0price list or cost in India. on <strong>Mr. Tarun:- +91 9891 296 838 \/ Mr. Neeraj:- +91 9811 747 774.<\/strong><\/em><\/p>\n<p><strong><a href=\"https:\/\/indianpharmanetwork.co.in\/about-ipn.php\">Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a><\/strong>. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as\u00a0<strong>Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik,<\/strong>\u00a0and various other regions in India.<\/p>\n","protected":false},"featured_media":8411,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[222],"product_tag":[271,270],"class_list":{"0":"post-8398","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-deficiency-disorder","7":"product_tag-gilteritinib","8":"product_tag-xospata","10":"first","11":"instock","12":"shipping-taxable","13":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/8398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/8411"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=8398"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=8398"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=8398"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=8398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}